Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can time with horses help cancer patients feel better?

NCT ID NCT07831460

NEW Symptom relief Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing whether a structured program of interactions with horses improves quality of life for young people and women who have finished chemotherapy or radiotherapy for cancer or blood disorders. Participants are randomly assigned to receive standard follow-up care alone or standard care plus horse-assisted sessions. The trial measures changes in quality of life, symptom burden, and body mass index.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Horse-Assisted Intervention, a structured program of interactions with horses
What this could lead to
If it helps, this could give cancer centers a non-drug way to lift quality of life and ease symptoms during recovery.
What could go wrong
The trial is small, with 28 participants, and results may not hold for other patients or centers. Time with horses also carries a risk of injury, and any benefit may come simply from getting out and doing something enjoyable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

28 people

The number who actually took part.

Started

Jun 2021

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescents-Young adults (16 - 39 years old) of both sexes with onco-hematological cancer at any stage who have completed chemotherapy and/or radiotherapy at least 3 months before enrolment * Women (18 - 65 years) with breast cancer who have completed chemotherapy and/or radiotherapy at least 3 months before enrolment * ECOG PS 0-1 * Written informed consent * Subjects who don't practice any other equestrian sport * Life expectancy greater than 6 months * Subjects who are able to understand the study and cooperate according to study procedures, based on Investigator's opinion. Exclusion Criteria: * Horse Allergy * Critical Bone lesions * Moderate to severe neutropenia * Moderate to severe Thrombocytopenia * ECOG PS\>2 * Uncontrolled epilepsy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hematologic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Haematologic disease Oncologic disorders

Contacts and locations

Locations

  • Infermi Hospital Hematology Department, AUSL Romagna

    Rimini, 47923, Italy

  • Infermi Hospital Onco - Hematology Pediatric Department

    Rimini, 47923, Italy

  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS

    Meldola, FC, 47014, Italy

  • Santa Maria delle Croci Hospital Hematology Department, AUSL Romagna

    Ravenna, RA, 48121, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.